Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  American Journal of Pathology

• Publication date

  2002-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0002-9440(10)64487-2PMID 12466125PMCID PMC1850911
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• α-Synuclein Protects against Oxidative Stress via Inactivation of the c-Jun N-terminal Kinase Stress-signaling Pathway in Neuronal Cells*

  2002cited by this paper
• Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans.

  2002cited by this paper
• Proteasomal inhibition leads to formation of ubiquitin/α‐synuclein‐immunoreactive inclusions in PC12 cells

  2001cited by this paper
• alpha-Synuclein forms a complex with transcription factor Elk-1.

  2001cited by this paper
• Alpha-synuclein and neurodegenerative diseases

  2001cited by this paper
• Alpha-synuclein and the Lewy body disorders.

  2001cited by this paper
• Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia

  2001cited by this paper
• Phosphorylated Map Kinase (ERK1, ERK2) Expression is Associated with Early Tau Deposition in Neurones and Glial Cells, but not with Increased Nuclear DNA Vulnerability and Cell Death, in Alzheimer Disease, Pick's Disease, Progressive Supranuclear Palsy and Corticobasal Degeneration

  2001cited by this paper
• Sustained extracellular signal‐regulated kinase activation by 6‐hydroxydopamine: implications for Parkinson's disease

  2001cited by this paper
• α‐Synuclein forms a complex with transcription factor Elk‐1

  2001cited by this paper
• Failure of the ubiquitin–proteasome system in Parkinson's disease

  2001cited by this paper
• Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular Toxicity

  2001cited by this paper
• Synucleinopathies: clinical and pathological implications.

  2001cited by this paper
• Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.

  2001cited by this paper
• Epidermal Growth Factor Induces Oxidative Neuronal Injury in Cortical Culture

  2000cited by this paper
• The Recruitment of Raf-1 to Membranes Is Mediated by Direct Interaction with Phosphatidic Acid and Is Independent of Association with Ras*

  2000cited by this paper
• Ubiquitin Immunochemistry as a Diagnostic Aid for Community Pathologists Evaluating Patients Who Have Dementia

  2000cited by this paper
• Lewy Bodies in Alzheimer's Disease: A Neuropathological Review of 145 Cases Using α‐Synuclein Immunohistochemistry

  2000cited by this paper
• Persistent Activation of ERK Contributes to Glutamate-induced Oxidative Toxicity in a Neuronal Cell Line and Primary Cortical Neuron Cultures*

  2000cited by this paper
• α-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining

  2000cited by this paper
• Long‐Term Depression in the Hippocampus In Vivo Is Associated with Protein Phosphatase‐Dependent Alterations in Extracellular Signal‐Regulated Kinase

  2000cited by this paper
• Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease

  2000cited by this paper
• Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons.

  2000cited by this paper
• alpha-Synuclein shares physical and functional homology with 14-3-3 proteins.

  1999cited by this paper
• Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation.

  1999cited by this paper
• MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia.

  1999cited by this paper
• α-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins

  1999cited by this paper
• CREB Phosphorylation Promotes Nerve Cell Survival

  1999cited by this paper
• Induction of an Immediate Early Gene egr‐1 by Zinc Through Extracellular Signal‐Regulated Kinase Activation in Cortical Culture

  1999cited by this paper
• Mitogen-activated protein kinase pathway mediates peroxynitrite-induced apoptosis in human dopaminergic neuroblastoma SH-SY5Y cells.

  1999cited by this paper
• Iron metabolism and Parkinson's disease.

  1998cited by this paper
• Regional Selective Neuronal Degeneration after Protein Phosphatase Inhibition in Hippocampal Slice Cultures: Evidence for a MAP Kinase-Dependent Mechanism

  1998cited by this paper
• Understanding cell death in parkinson's disease

  1998cited by this paper
• Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII).

  1997cited by this paper
• Rapid brain autopsy. The Joseph and Kathleen Bryan Alzheimer's Disease Research Center experience.

  1997cited by this paper
• Intracellular signaling pathways activated by neurotrophic factors.

  1996cited by this paper
• Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis

  1995cited by this paper
• Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease.

  1991cited by this paper
• The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

  1988cited by this paper
• Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation.

  1983cited by this paper
• Putative neurotransmitters in clonal cell lines

  1975cited by this paper
• Clonal cell lines from the rat central nervous system

  1974cited by this paper
• CONCENTRIC HYALIN INTRANEURONAL INCLUSIONS OF LEWY TYPE IN THE BRAINS OF ELDERLY PERSONS (50 INCIDENTAL CASES): RELATIONSHIP TO PARKINSONISM

  1969cited by this paper

• BDNF and miRNAs in acupuncture-regulated neuroplasticity: Emerging mechanisms and therapeutic strategies

  2026cites this paper
• Roles of MAPKs, Including Those Activated by BDNF/TrkB, and Their Contribution in Neurodegenerative Diseases

  2026cites this paper
• The American Journal of Pathology and the American Society for Investigative Pathology: Forging the Next Century of Insights into Mechanisms of Disease.

  2025cites this paper
• Phosphoproteome modifications and cortical circuit dysfunction are linked to the early-stage progression of alpha-synuclein aggregation

  2025cites this paper
• Regulatory mechanisms and therapeutic potential of natural microglia inhibitors in Parkinson's disease.

  2025cites this paper
• Experience-dependent MAPK/ERK signaling in glia regulates critical period remodeling of synaptic glomeruli.

  2024cites this paper
• Clinical Trial Highlights: Anti-Inflammatory and Immunomodulatory Agents

  2024cites this paper
• Prospects for Disease Slowing in Parkinson Disease.

  2024cites this paper
• Nuclear pore and nucleocytoplasmic transport impairment in oxidative stress-induced neurodegeneration: relevance to molecular mechanisms in Pathogenesis of Parkinson’s and other related neurodegenerative diseases

  2024cites this paper
• Mutant α-synuclein causes death of human cortical neurons via ERK1/2 and JNK activation

  2024cites this paper
• Antioxidant and Antineuroinflammatory Mechanisms of Kaempferol-3-O-β-d-Glucuronate on Lipopolysaccharide-Stimulated BV2 Microglial Cells through the Nrf2/HO-1 Signaling Cascade and MAPK/NF-κB Pathway

  2023cites this paper
• Ethyl pyruvate protects SHSY5Y cells against 6-hydroxydopamine-induced neurotoxicity by upregulating autophagy

  2023cites this paper
• Paraquat and Parkinson’s Disease: The Molecular Crosstalk of Upstream Signal Transduction Pathways Leading to Apoptosis

  2023cites this paper
• Neuroprotective role of FOXA1 in Parkinson's disease: involvements of NF1 transcription activation and MAPK signaling pathway inhibition.

  2023cites this paper
• Entanglement of MAPK pathways with gene expression and its omnipresence in the etiology for cancer and neurodegenerative disorders.

  2023cites this paper
• Oncogenic Pathways in Neurodegenerative Diseases

  2022cites this paper
• Association between plasma proteome and childhood neurodevelopmental disorders: A two-sample Mendelian randomization analysis

  2022cites this paper
• Protective Effect of Amber Extract on Human Dopaminergic Cells against 6-Hydroxydopamine-Induced Neurotoxicity

  2022cites this paper
• Selectivity of Protein Interactions along the Aggregation Pathway of α-Synuclein

  2021cites this paper
• Roles of ERK/Akt signals in mitochondria-dependent and endoplasmic reticulum stress-triggered neuronal cell apoptosis induced by 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene, a major active metabolite of bisphenol A.

  2021cites this paper
• Identification of Potential Core Genes in Parkinson's Disease Using Bioinformatics Analysis

  2021cites this paper
• Prolyl Oligopeptidase Regulates Dopamine Transporter Oligomerization and Phosphorylation in a PKC- and ERK-Independent Manner

  2021cites this paper
• Selectivity of Lewy body protein interactions along the aggregation pathway of α-synuclein

  2021cites this paper
• The Tyrosine Phosphatase hPTPRβ Controls the Early Signals and Dopaminergic Cells Viability via the P2X7 Receptor

  2021cites this paper
• RNF144a induces ERK-dependent cell death under oxidative stress via downregulation of vaccinia-related kinase 3

  2020cites this paper
• MAPK/ERK Dysfunction in Neurodegenerative Diseases

  2020cites this paper
• MAP/ERK Signaling in Developing Cognitive and Emotional Function and Its Effect on Pathological and Neurodegenerative Processes

  2020cites this paper
• Molecular Regulation in Dopaminergic Neuron Development. Cues to Unveil Molecular Pathogenesis and Pharmacological Targets of Neurodegeneration

  2020cites this paper
• The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration

  2020cites this paper
• Cr(VI) induces ROS-mediated mitochondrial-dependent apoptosis in neuronal cells via the activation of Akt/ERK/AMPK signaling pathway.

  2020cites this paper
• Knockdown of long non-coding RNA AL049437 mitigates MPP+ -induced neuronal injury in SH-SY5Y cells via the microRNA-205-5p/MAPK1 axis.

  2020cites this paper
• The process of Lewy body formation, rather than simply alpha-synuclein fibrillization, is the major driver of neurodegeneration in synucleinopathies

  2019cites this paper
• Unveiling the olfactory proteostatic disarrangement in Parkinson's disease by proteome-wide profiling.

  2019cites this paper
• Mechanisms of selective autophagy and mitophagy: Implications for neurodegenerative diseases.

  2019cites this paper
• The testosterone metabolite 3α-androstanediol inhibits oxidative stress-induced ERK phosphorylation and neurotoxicity in SH-SY5Y cells through an MKP3/DUSP6-dependent mechanism.

  2019cites this paper
• The Role of PI3K/Akt and ERK in Neurodegenerative Disorders

  2019cites this paper
• The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms

  2018cites this paper
• Rutin hydrate ameliorates cadmium chloride-induced spatial memory loss and neural apoptosis in rats by enhancing levels of acetylcholine, inhibiting JNK and ERK1/2 activation and activating mTOR signalling

  2018cites this paper
• Excitatory Dendritic Mitochondrial Calcium Toxicity: Implications for Parkinson’s and Other Neurodegenerative Diseases

  2018influential citation
• Silymarin recovers 6-hydroxydopamine-induced motor deficits in mice.

  2018cites this paper
• Aldose reductase deficiency leads to oxidative stress-induced dopaminergic neuronal loss and autophagic abnormality in an animal model of Parkinson's disease.

  2017cites this paper
• Humulus japonicus Prevents Dopaminergic Neuron Death in 6-Hydroxydopamine-Induced Models of Parkinson's Disease

  2017cites this paper
• Aging and Parkinson’s Disease: Different Sides of the Same Coin?

  2017cites this paper
• Effect of Oleracein E, a Neuroprotective Tetrahydroisoquinoline, on Rotenone-Induced Parkinson's Disease Cell and Animal Models.

  2017cites this paper
• Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patients

  2017cites this paper
• Cerebellar Insulin/IGF-1 signaling in diabetic rats: Effects of exercise training.

  2017cites this paper
• Integral Characterization of Defective BDNF/TrkB Signalling in Neurological and Psychiatric Disorders Leads the Way to New Therapies

  2017cites this paper
• Noncoding RNA Regulation of Dopamine Signaling in Diseases of the Central Nervous System

  2016cites this paper
• Stress-induced nuclear translocation of CDK5 suppresses neuronal death by downregulating ERK activation via VRK3 phosphorylation

  2016cites this paper
• Agmatine Protects Against 6-OHDA-Induced Apoptosis, and ERK and Akt/GSK Disruption in SH-SY5Y Cells

  2016cites this paper
• VRK3-mediated nuclear localization of HSP70 prevents glutamate excitotoxicity-induced apoptosis and Aβ accumulation via enhancement of ERK phosphatase VHR activity

  2016cites this paper
• The Role of Caffeine in Neurodegenerative Diseases: Possible Genetic and Cellular Signaling Mechanisms

  2015cites this paper
• Autoantibody-mediated cytotoxicity in paediatric opsoclonus-myoclonus syndrome is dependent on ERK-1/2 phophorylation.

  2015cites this paper
• PROTEOMICS AND PHOSPHOPROTEOMICS OF BRAIN: (1) ANALYSES OF THE PINK1 KNOCKOUT MODEL OF PARKINSON DISEASE; (2) INSIGHTS INTO THE PROGRESSION OF ALZHEIMER DISEASE; AND (3) THE NAKED MOLE-RAT MODEL OF SALUBRIOUS AGING

  2015cites this paper
• Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease

  2015cites this paper
• Parkinson’s disease-implicated kinases in the brain; insights into disease pathogenesis

  2014influential citation
• ERKed by LRRK2: a cell biological perspective on hereditary and sporadic Parkinson's disease.

  2014cites this paper
• Kinase Signalling in Huntington's Disease

  2014cites this paper
• ERK-mediated phosphorylation of TFAM downregulates mitochondrial transcription: implications for Parkinson's disease.

  2014cites this paper
• Protein kinase C delta mediated cytotoxicity of 6-Hydroxydopamine via sustained extracellular signal-regulated kinase 1/2 activation in PC12 cells

  2014cites this paper
• Mycobacteria Bypass Mucosal NF-kB Signalling to Induce an Epithelial Anti-Inflammatory IL-22 and IL-10 Response

  2014cites this paper
• Decreased SIRT2 activity leads to altered microtubule dynamics in oxidatively-stressed neuronal cells: implications for Parkinson's disease.

  2014cites this paper
• Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives.

  2014cites this paper
• The Effects of Androgens on Hippocampal Synaptic Plasticity in Male Mammals

  2014cites this paper
• miR-7 and miR-153 protect neurons against MPP+-induced cell death via upregulation of mTOR pathway

  2014cites this paper
• The roles of cyclic AMP-ERK-Bad signaling pathways on 6-hydroxydopamine-induced cell survival and death in PC12 cells.

  2013cites this paper
• Valproic acid ameliorates C. elegans dopaminergic neurodegeneration with implications for ERK-MAPK signaling.

  2013cites this paper
• After the banquet

  2013cites this paper
• Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease.

  2013influential citation
• The Role of β-Adrenergic Blockers in Parkinson’s Disease

  2013cites this paper
• The Beneficial Role of Thiamine in Parkinson Disease

  2013cites this paper
• The Raf-1 inhibitor GW5074 and the ERK1/2 pathway inhibitor U0126 ameliorate PC12 cells apoptosis induced by 6-hydroxydopamine.

  2012cites this paper
• The Protease Omi Cleaves the Mitogen-Activated Protein Kinase Kinase MEK1 to Inhibit Microglial Activation

  2012cites this paper
• Altered transcription factor trafficking in oxidatively-stressed neuronal cells.

  2012cites this paper
• Vitamin D and Parkinson's disease.

  2012cites this paper
• Oxidative Stress Does Not Predispose Neuronal Cells to Changes in G Protein Coupled (Opioid) Receptor Gene Expression in Cortical B50 Neurons in Culture

  2012cites this paper
• Vitamin D and Parkinson's disease

  2012cites this paper
• Non-viral gene delivery of the GDNF, either alone or fused to the C-fragment of tetanus toxin protein, prolongs survival in a mouse ALS model

  2012cites this paper
• Extracellular signal-regulated kinase is involved in alpha-synuclein-induced mitochondrial dynamic disorders by regulating dynamin-like protein 1.

  2012cites this paper
• Nuclear transport, oxidative stress, and neurodegeneration.

  2011cites this paper
• Diversity in the Regulation of Autophagy and Mitophagy: Lessons from Parkinson's Disease

  2011cites this paper
• Single-Cell Redox Imaging Demonstrates a Distinctive Response of Dopaminergic Neurons to Oxidative Insults

  2011cites this paper
• Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates

  2011cites this paper
• Peroxiredoxin-2 Protects against 6-Hydroxydopamine-Induced Dopaminergic Neurodegeneration via Attenuation of the Apoptosis Signal-Regulating Kinase (ASK1) Signaling Cascade

  2011cites this paper
• PI3-K/Akt and ERK pathways activated by VEGF play opposite roles in MPP+-induced neuronal apoptosis.

  2011cites this paper
• Protein localization in disease and therapy

  2011cites this paper
• Estudio de las vías de supervivencia y muerte neuronal en modelos de la enfermedad de Huntington

  2010cites this paper
• Mesenchymal stem cells inhibition of chronic ethanol-induced oxidative damage via upregulation of phosphatidylinositol-3-kinase/Akt and modulation of extracellular signal-regulated kinase 1/2 activation in PC12 cells and neurons.

  2010cites this paper
• Activation of the integrated stress response in HIV-associated neurocognitive disorder

  2010cites this paper
• Alterations in mGluR5 Expression and Signaling in Lewy Body Disease and in Transgenic Models of Alpha-Synucleinopathy – Implications for Excitotoxicity

  2010influential citation
• Ethyl pyruvate has a neuroprotective effect through activation of extracellular signal-regulated kinase in Parkinson's disease model.

  2010cites this paper
• Aberrant ERK 1/2 complex activation and localization in scrapie-infected GT1-1 cells

  2010cites this paper
• α‐Synuclein expression is induced by depolarization and cyclic AMP in enteric neurons

  2010cites this paper
• ERK and cell death: ERK1/2 in neuronal death

  2010cites this paper
• Opposing effects of ERK and p38‐JNK MAP kinase pathways on formation of prions in GT1‐1 cells

  2009cites this paper
• Role of protein phosphatases and mitochondria in the neuroprotective effects of estrogens.

  2009cites this paper
• Discovery of a nitric oxide synthase-dependent response and a functional analysis of genes regulating the response in a Drosophila model of Parkinson's disease

  2009cites this paper
• Fibroblasts from long-lived mutant mice show diminished ERK1/2 phosphorylation but exaggerated induction of immediate early genes.

  2009cites this paper
• The role of D1 dopamine receptors and phospho-ERK in mediating cytotoxicity. Commentary

  2009cites this paper
• Mitochondrial quality control: insights on how Parkinson’s disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis

  2009cites this paper